Tajikistan vs Togo: HIV-positive TB patients on ART (antiretroviral therapy)
Tajikistan
100.0%
in 2024
Togo
100.0%
in 2024
Tajikistan rank
1st
Togo rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Tajikistan
- Togo
How they compare
Tajikistan currently reports 100.0% against 100.0% in Togo, a difference of 0.0%.
The two have swapped places 5 times across 16 shared years of data; in 2008 it was Tajikistan ahead.
Tajikistan ranks 1st and Togo ranks 1st of 144 countries.
Across the 3 decades both report, Tajikistan averaged higher in 1 and Togo in 2.
Head to head by decade
| Decade | Tajikistan | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 40.0% | 33.0% | 7.0% | Tajikistan |
| 2010s | 74.2% | 84.4% | 10.2% | Togo |
| 2020s | 97.8% | 99.2% | 1.4% | Togo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Tajikistan or Togo?
- Tajikistan, at 100.0% against 100.0% in Togo as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Tajikistan and Togo?
- 0.0%, with Tajikistan ahead.
- How many years of comparable data are there for Tajikistan and Togo?
- 16 years are reported by both, from 2008 to 2024.
- How do Tajikistan and Togo rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Tajikistan ranks 1st and Togo ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.